TFBS Bioscience Inc. (TPEX:6939)
Taiwan
· Delayed Price · Currency is TWD 24.45
+3.50 (16.71%)
Apr 29, 2026, 1:48 PM CST
TFBS Bioscience Market Cap
TFBS Bioscience has a market cap or net worth of 854.26 million as of April 29, 2026. Its market cap has decreased by -14.01% in one year.
Market Cap
854.26M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
24.45
Market Cap Chart
Since May 15, 2023, TFBS Bioscience's market cap has decreased from 2.35B to 854.26M, a decrease of -63.63%. That is a compound annual growth rate of -28.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 854.26M | 14.25% |
| Dec 31, 2025 | 747.70M | -24.34% |
| Dec 31, 2024 | 988.18M | -39.96% |
| Dec 29, 2023 | 1.65B | -29.93% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sofiva Genomics | 712.58M |
| Puriblood Medical | 710.08M |
| Kim Forest Enterprise | 772.96M |
| Pharmigene | 504.65M |
| Genetics Generation Advancement | 1.16B |
| Welgene Biotech | 431.13M |
| DIVA Laboratories | 1.87B |
| BIONET | 3.80B |